These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10360473)

  • 21. Prevalence of self-reported respiratory symptoms in workers exposed to isocyanates.
    Sari-Minodier I; Charpin D; Signouret M; Poyen D; Vervloet D
    J Occup Environ Med; 1999 Jul; 41(7):582-8. PubMed ID: 10412099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exposure-response relationships in asthma caused by tetrachlorophthalic anhydride.
    Venables KM; Newman Taylor AJ
    J Allergy Clin Immunol; 1990 Jan; 85(1 Pt 1):55-8. PubMed ID: 2299106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New methodology for specific inhalation challenges with occupational agents.
    Caron S; Boileau JC; Malo JL; Leblond S
    Respir Res; 2010 Jun; 11(1):72. PubMed ID: 20534154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a 4-steps-1-day whole body challenge protocol for the diagnosis of occupational asthma due to diisocyanates.
    Scheidler L; Sucker K; Taeger D; van Kampen V; Heinze E; Marczynski B; Monsé C; Brüning T; Merget R
    Adv Exp Med Biol; 2013; 788():301-11. PubMed ID: 23835991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Occupational asthma: an experimental asthma. Apropos of isocyanate-induced asthma].
    Pauli G; Kopferschmitt MC; Dietemann A; Blaumeiser M; Bessot JC
    Rev Pneumol Clin; 1993; 49(3):115-9. PubMed ID: 8296138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperazine-induced occupational asthma.
    Hagmar L; Bellander T; Bergöö B; Simonsson BG
    J Occup Med; 1982 Mar; 24(3):193-7. PubMed ID: 7062155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk factors and pathogenesis of occupational asthma].
    Pałgan K; Dziedziczko A
    Pol Merkur Lekarski; 2003 Jan; 14(79):62-4. PubMed ID: 12712833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Absence of association of specific and nonspecific bronchial hyperreactivity in occupational asthma caused by platinum salts].
    Merget R; Dierkes A; Rückmann A; Bergmann EM; Schultze-Werninghaus G
    Pneumologie; 1997 Apr; 51(4):345-50. PubMed ID: 9221380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occupational asthma caused by isocyanates: patterns of asthmatic reactions to increasing day-to-day doses.
    Malo JL; Ghezzo H; Elie R
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1879-83. PubMed ID: 10351934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New aspects of isocyanate asthma.
    Baur X
    Lung; 1990; 168 Suppl():606-13. PubMed ID: 2117170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma.
    Bernstein DI; Cartier A; Côté J; Malo JL; Boulet LP; Wanner M; Milot J; L'Archevéque J; Trudeau C; Lummus Z
    Am J Respir Crit Care Med; 2002 Aug; 166(4):445-50. PubMed ID: 12186818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Occupational isocyanate-induced asthma].
    Orosz M; Nagy L; Galambos E
    Orv Hetil; 1984 Aug; 125(32):1931-4. PubMed ID: 6472839
    [No Abstract]   [Full Text] [Related]  

  • 33. [Incidence and various conditions of bronchial hypersensitivity in workers of the nitrogen processing plants (preliminary report)].
    Gondorowicz K; Rozniecki J
    Pneumonol Pol; 1979; 47(7-8):523-5. PubMed ID: 537938
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperreactivity in clinical practice--induction by occupational factors.
    Belin L
    Eur J Respir Dis Suppl; 1983; 131():285-302. PubMed ID: 6581984
    [No Abstract]   [Full Text] [Related]  

  • 35. Occupational asthma prevention and management in industry--an example of a global programme.
    Gannon PF; Berg AS; Gayosso R; Henderson B; Sax SE; Willems HM
    Occup Med (Lond); 2005 Dec; 55(8):600-5. PubMed ID: 16314331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morphological and functional changes in the bronchi caused by chemical substances used in the production of paints and lacquers as a pathogenic factor of occupational bronchial asthma. II. Nonspecific bronchial hyperreactivity in workers in a paint and lacquer plant].
    Liebhart J; Liebhart E; Jankowska R; Kraus-Filarska M; Panaszek B; Szeliga W; Kapłońska J; Madej JA
    Pneumonol Pol; 1983 Jul; 51(7):393-9. PubMed ID: 6647046
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcome of asthma induced by isocyanates.
    Lozewicz S; Assoufi BK; Hawkins R; Taylor AJ
    Br J Dis Chest; 1987 Jan; 81(1):14-22. PubMed ID: 3663485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the respiratory retention of inhaled hexamethylene di-isocyanate?
    Monso E; Cloutier Y; Lesage J; Perreault G; Malo JL
    Eur Respir J; 2000 Oct; 16(4):729-30. PubMed ID: 11106220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bronchial asthmatic disease associated with tobacco dust--an occupational lung disease?].
    Haber H; Raber W; Vetter N
    Wien Klin Wochenschr; 2004; 116 Suppl 1():38-9. PubMed ID: 15518090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isocyanate exposure and asthma in the UK vehicle repair industry.
    Stocks SJ; Jones K; Piney M; Agius RM
    Occup Med (Lond); 2015 Dec; 65(9):713-8. PubMed ID: 26209793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.